DNER and rhabdomyosarcoma: The efficacy of BET and PI3K inhibitors was demonstrated in alveolar and embryonal rhabdomyosarcoma cell lines where the combination of JQ1 and the PI3K inhibitor BYL719 gave synergistic effects in rhabdomyosarcoma cells causing G1 arrest and caspase-dependent apoptosis [241].